Cyclerion Therapeutics Correlations

CYCN Stock  USD 2.57  0.04  1.58%   
The current 90-days correlation between Cyclerion Therapeutics and Hoth Therapeutics is -0.05 (i.e., Good diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cyclerion Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cyclerion Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Cyclerion Therapeutics Correlation With Market

Significant diversification

The correlation between Cyclerion Therapeutics and DJI is 0.04 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Cyclerion Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cyclerion Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
To learn how to invest in Cyclerion Stock, please use our How to Invest in Cyclerion Therapeutics guide.

Moving together with Cyclerion Stock

  0.64DRRX DurectPairCorr

Moving against Cyclerion Stock

  0.6A Agilent Technologies Earnings Call TomorrowPairCorr
  0.41VCYT VeracytePairCorr
  0.31VERA Vera TherapeuticsPairCorr
  0.43VRDN Viridian TherapeuticsPairCorr
  0.31VRNA Verona Pharma PLCPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Risk-Adjusted Indicators

There is a big difference between Cyclerion Stock performing well and Cyclerion Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Cyclerion Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Cyclerion Therapeutics Corporate Management

Todd MilneSenior InnovationProfile
Cheryl GaultChief OfficerProfile
Jessica RennekampAssociate CommunicationsProfile
Christopher WinrowSr LeadProfile
Jennifer ChickeringDirector StrategyProfile
Rhonda ChickoChief OfficerProfile